Chlorpromazine's Potential Role in Palliating Distressing Symptoms Associated with Hyperactive Delirium in Patients at End of Life.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of palliative medicine"
DOI: 10.1089/jpm.2022.0308
Abstract: Background: The hyperactive subtype of delirium is characterized by agitation, restlessness, delusions, and/or hallucinations, which commonly present near end of life (EoL). Symptom relief often requires the use of medications, such as chlorpromazine (CPZ), to… read more here.
Keywords: delirium patients; end life; delirium; hyperactive delirium ... See more keywords